{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:21:53Z","timestamp":1791328913094,"version":"4.3.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T00:00:00Z","timestamp":1391990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.fertnstert.2014.02.008","type":"journal-article","created":{"date-parts":[[2014,3,15]],"date-time":"2014-03-15T09:15:49Z","timestamp":1394874949000},"page":"1565-1573.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":275,"title":["Long-term treatment of uterine fibroids with ulipristal acetate\u2606"],"prefix":"10.1016","volume":"101","clinical-trial-number":[{"clinical-trial-number":"nct01156857","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01252069","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jacques","family":"Donnez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Tomaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.J.M.","family":"Fauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Donnez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Bestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Osterloh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Loumaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2014.02.008_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing","volume":"369","author":"Mehine","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.AOG.0000136079.62513.39","article-title":"Uterine myomas: an overview of development, clinical features, and management","volume":"104","author":"Wallach","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib4","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/humrep\/17.6.1424","article-title":"What are the implications of myomas on fertility? A need for a debate?","volume":"17","author":"Donnez","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1056\/NEJMe1114043","article-title":"Uterine fibroids and evidence-based medicine\u2014not an oxymoron","volume":"366","author":"Stewart","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0015-0282(16)60723-9","article-title":"Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography","volume":"51","author":"Donnez","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib7","first-page":"0814","article-title":"Fibroids (uterine myomatosis, leiomyomas)","volume":"2011","author":"Lethaby","year":"2011","journal-title":"Clin Evid (Online)"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.contraception.2010.02.011","article-title":"Intrauterine device use among women with uterine fibroids: a systematic review","volume":"82","author":"Zapata","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/17425255.2012.695775","article-title":"Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment","volume":"8","author":"Melis","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0039-128X(03)00130-2","article-title":"Pharmacologic properties of CDB(VA)-2914","volume":"68","author":"Gainer","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib11","doi-asserted-by":"crossref","first-page":"436174","DOI":"10.1155\/2012\/436174","article-title":"Effect of a selective progesterone receptor modulator on induction of apoptosis in uterine fibroids in\u00a0vivo","volume":"2012","author":"Horak","year":"2012","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jcpt.12065","article-title":"Ulipristal acetate\u2014safety and pharmacokinetics following multiple doses of 10\u201350 mg per day","volume":"38","author":"Pohl","year":"2013","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","article-title":"The spectrum of endometrial pathology induced by progesterone receptor modulators","volume":"21","author":"Mutter","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib16","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.humpath.2010.11.003","article-title":"Distinguishing features of endometrial pathology after exposure to the progesterone receptor modulator mifepristone","volume":"42","author":"Fiscella","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/modpathol.2008.204","article-title":"Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator","volume":"22","author":"Ioffe","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib19","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","article-title":"The short-form McGill Pain Questionnaire","volume":"30","author":"Melzack","year":"1987","journal-title":"Pain"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib21","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib22","first-page":"290","article-title":"The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib23","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/01.AOG.0000243776.23391.7b","article-title":"Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial","volume":"108","author":"Fiscella","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/AOG.0b013e3181ed36b3","article-title":"Outcomes from leiomyoma therapies: comparison with normal controls","volume":"116","author":"Spies","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1080\/09513590802454901","article-title":"Elevated level of plasma vascular endothelial growth factor after gonadotropin-releasing hormone agonist treatment for leiomyomata","volume":"24","author":"Takeda","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib26","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.acra.2011.03.008","article-title":"MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes","volume":"18","author":"Kim","year":"2011","journal-title":"Acad Radiol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mce.2011.05.044","article-title":"The role of progesterone signaling in the pathogenesis of uterine leiomyoma","volume":"358","author":"Kim","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0015-0282(16)57729-2","article-title":"Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri","volume":"64","author":"Scialli","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2010.09.059","article-title":"Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study","volume":"95","author":"Nieman","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib32","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0029-7844(95)00062-V","article-title":"A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss","volume":"85","author":"Janssen","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib33","doi-asserted-by":"crossref","first-page":"209.e1","DOI":"10.1016\/j.ajog.2010.10.897","article-title":"Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia","volume":"204","author":"Philipp","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000320336","article-title":"Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin","volume":"71","author":"Zakherah","year":"2011","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib35","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.1365-2516.2002.00678.x","article-title":"DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study","volume":"8","author":"Kadir","year":"2002","journal-title":"Haemophilia"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2141.2009.07610.x","article-title":"Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid","volume":"145","author":"Kouides","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib37","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1447-0756.2008.00987.x","article-title":"Efficacy and safety of ormeloxifene in management of menorrhagia: a pilot study","volume":"35","author":"Kriplani","year":"2009","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib38","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1471-0528.2005.00642.x","article-title":"Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts","volume":"112","author":"Reid","year":"2005","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib39","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/01.ogx.0000224663.62282.b9","article-title":"A randomized trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding","volume":"61","author":"Busfield","year":"2006","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","article-title":"The Short-Form McGill Pain Questionnaire","volume":"30","author":"Melzack","year":"1987","journal-title":"Pain"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib41","first-page":"290","article-title":"The UFS-QOL, a new disease-specific symptom and health-related quality\u00a0of\u00a0life questionnaire for leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","article-title":"The spectrum of endometrial pathology induced by progesterone receptor modulators","volume":"21","author":"Mutter","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.fertnstert.2014.02.008_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/pst.337","article-title":"Assessing the impact of ICH E9","volume":"7","author":"Brown","year":"2008","journal-title":"Pharm Stat"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214001460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214001460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:12:48Z","timestamp":1762150368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028214001460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0015028214001460"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.02.008","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718312286.793539264","asserted-by":"object"}]},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term treatment of uterine fibroids with ulipristal acetate\u2606","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}